PharmAnt.com

14/09/2022

FDA approved Imfinzi plus chemotherapy as a first-line treatment regimen for advanced biliary tract cancer

Biliary tract cancer (BTC) is a form of gastrointestinal cancer that occurs in the bile duct, gallbladder, and ampulla of Vater (an area where the bile duct and pancreas join to open to the small inte

30/08/2022

📰 YH001: FDA Approved Investigational New Drug Application

The FDA approved the Investigational New Drug application for initiating a Phase 1/2 clinical study of YH001 in combination with envafolimab and doxorubicin to treat sarcoma patients, including patien

02/12/2020

Check FDA approvals for Nov 2020

https://pharmant.com/fda-approvals-nov-2020/

During November three (3) indications/molecules were approved by FDA: Sonalleve MR-HIFU system for the treatment of osteoid osteoma in the extremities.

24/11/2020

Learn more about on

Beta thalassemias is an inherited blood disorder that results from reduced or absent synthesis of the beta chains of hemoglobin. The ineffective and low level of hemoglobin usually result in the

20/11/2020

Learn more about "Rare Disorders" with PharmAnt. Simple 1 to 2 minutes reading articles that give you an overall view of "Rare disorders" that you never heard about before.

Visit PharmAnt.com today and enjoy

PharmAnt "Your Medical Hub"

19/11/2020

https://pharmant.com/b-cell-lymphoma/

B-cell lymphomas is a type of blood cancer that developed more frequently in immunocompromised patient and elders. It affect B cell and include several types

17/11/2020

https://pharmant.com/could-your-esophagus-change-into-intestine/

It is a rare medical condition where the esophagus cells start to transform in to cells similar to those we have in our intestine. Despite being a rare condition, it is more

16/11/2020

🩸 Aplastic Anemia Symptoms



https://pharmant.com/aplastic-anemia-symptoms/

12/11/2020

⭕️ Is Anthrax Dangerous?


https://lnkd.in/gF3Pnia

10/11/2020

09/11/2020

PFIZER AND BIONTECH ANNOUNCE VACCINE CANDIDATE AGAINST COVID-19 ACHIEVED SUCCESS IN FIRST INTERIM ANALYSIS FROM PHASE 3 STUDY

07/11/2020